These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2469662)

  • 21. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
    Ayalon D; Farhi Y; Comaru-Schally AM; Schally AV; Eckstein N; Vagman I; Limor R
    Neuroendocrinology; 1993 Aug; 58(2):153-9. PubMed ID: 8264861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone.
    Haviv F; Fitzpatrick TD; Nichols CJ; Bush EN; Diaz G; Bammert G; Nguyen AT; Johnson ES; Knittle J; Greer J
    J Med Chem; 1994 Mar; 37(5):701-5. PubMed ID: 7510341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT
    Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovulation inhibition in the pregnant mare's serum gonadotropin-treated immature rat: a bioassay for luteinizing hormone-releasing hormone antagonists.
    Sundaram K; Schmidt F; Thau RB
    Biol Reprod; 1984 Dec; 31(5):920-4. PubMed ID: 6394060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
    Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
    J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonists of the luteinizing hormone releasing hormone (LHRH) with emphasis on the TRP7 of the salmon and chicken II LHRH's.
    Folkers K; Bowers CY; Shieh HM; Liu YZ; Xiao SB; Tang PF; Chu JY
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1221-6. PubMed ID: 6385974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine.
    Ljungqvist A; Feng DM; Tang PF; Kubota M; Okamoto T; Zhang YW; Bowers CY; Hook WA; Folkers K
    Biochem Biophys Res Commun; 1987 Oct; 148(2):849-56. PubMed ID: 2446602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH.
    Csernus VJ; Szende B; Groot K; Redding TW; Schally AV
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):111-8. PubMed ID: 2110458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological activity of LH-RH antagonists modified in position 1.
    Horvath A; Coy DH; Nekola MV; Coy EJ; Schally AV; Teplan I
    Peptides; 1982; 3(6):969-71. PubMed ID: 6762537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative potencies of antagonists of the luteinizing hormone releasing hormone with Lys8 and Arg8 and substitutions in positions 3, 5, 6, 7 and 8.
    Folkers K; Bowers C; Tang PF; Kobota M; Xiao SB; Bender W; Liu YZ
    Z Naturforsch C J Biosci; 1986; 41(11-12):1087-91. PubMed ID: 2437717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of GnRH antagonists on phorbol ester-induced LH release from rat pituitary gonadotrophs.
    Saito S; Izumi S; Umeuchi M; Makino T; Tsujimoto G; Nozawa S
    Endocr J; 1994 Aug; 41(4):415-9. PubMed ID: 8528357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory analogues of the luteinizing hormone-releasing hormone having D-aromatic residues in positions 2 and 6 and variation in position 3.
    Humphries J; Wan YP; Folkers K; Bowers CY
    J Med Chem; 1978 Jan; 21(1):120-3. PubMed ID: 338902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
    Burgos-Briceño LA; Schally AV; Bartke A; Asch RH
    J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.
    Reissmann T; Hilgard P; Harleman JH; Engel J; Comaru-Schally AM; Schally AV
    J Cancer Res Clin Oncol; 1992; 118(1):44-9. PubMed ID: 1530849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats.
    Schmidt F; Sundaram K; Thau RB; Bardin CW
    Contraception; 1984 Mar; 29(3):283-9. PubMed ID: 6375959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
    Nagy A; Schally AV; Armatis P; Szepeshazi K; Halmos G; Kovacs M; Zarandi M; Groot K; Miyazaki M; Jungwirth A; Horvath J
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7269-73. PubMed ID: 8692981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and bioassay of LHRH-antagonists with N-Ac-D-O-phenyltyrosine and N-Ac-D-3-(2-dibenzofuranyl)alanine in position 1.
    Ljungqvist A; Bowers CY; Folkers K
    Int J Pept Protein Res; 1993 May; 41(5):427-32. PubMed ID: 8320036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential actions of a mammalian gonadotropin-releasing hormone antagonist on gonadotropin-II and growth hormone release in goldfish, Carassius auratus.
    Murthy CK; Turner RJ; Wong AO; Rao PD; Rivier JE; Peter RE
    Neuroendocrinology; 1994 Jun; 59(6):561-71. PubMed ID: 8084380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.